KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rigel Pharmaceuticals (RIGL) Interest Coverage Ratio (2019 - 2025)

Rigel Pharmaceuticals has reported Interest Coverage Ratio over the past 9 years, most recently at 13.64 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 60.08% year-over-year to 13.64; the TTM value through Dec 2025 reached 17.14, up 460.99%, while the annual FY2025 figure was 17.14, 460.99% up from the prior year.
  • Interest Coverage Ratio for Q4 2025 was 13.64 at Rigel Pharmaceuticals, down from 15.01 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 86.09 in Q1 2021 and troughed at 22.79 in Q2 2022.
  • A 5-year average of 2.37 and a median of 1.07 in 2024 define the central range for Interest Coverage Ratio.
  • Biggest five-year swings in Interest Coverage Ratio: crashed 207.17% in 2022 and later surged 14700.2% in 2025.
  • Year by year, Interest Coverage Ratio stood at 16.49 in 2021, then surged by 111.39% to 1.88 in 2022, then crashed by 45.11% to 1.03 in 2023, then soared by 726.35% to 8.52 in 2024, then soared by 60.08% to 13.64 in 2025.
  • Business Quant data shows Interest Coverage Ratio for RIGL at 13.64 in Q4 2025, 15.01 in Q3 2025, and 32.61 in Q2 2025.